NIH Requests for Applications

  • Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32)
    (RFA-AG-17-063)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Revision Applications for U.S-South Africa Program for Collaborative Biomedical Research (R01)
    (RFA-AI-16-082)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Mental Health
    Application Receipt Date(s): March 28, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date .
  • Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research (U01)
    (RFA-AI-16-083)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date .
  • Development of Multipurpose Prevention Technologies: A Strategy for the Prevention of Sexually Transmitted Infections (STIs) (R61/R33)
    (RFA-AI-16-085)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): March 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Pilot Clinical Trials Targeting HIV-1 Reservoirs in Children (U01)
    (RFA-AI-16-086)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): March 14 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • PDX Development and Trial Centers (PDTCs) (U54)
    (RFA-CA-17-003)
    National Cancer Institute
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24)
    (RFA-CA-17-004)
    National Cancer Institute
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Mechanisms of Cancer Drug Resistance and Sensitivity (U54)
    (RFA-CA-17-009)
    National Cancer Institute
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
  • The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
    (RFA-CA-17-014)
    National Cancer Institute
    Application Receipt Date(s): February 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Optimizing the HIV Care Continuum for Substance Abusing Populations at High-Risk and/or Living with HIV (R01)
    (RFA-DA-17-024)
    National Institute on Drug Abuse
    Application Receipt Date(s): May 9, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
    (RFA-DK-16-505)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: Revision Application for the Human Islet Research Network Coordinating Center (U01)
    (RFA-DK-17-501)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Research Centers in Minority Institutions (U54)
    (RFA-MD-17-003)
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Frontotemporal Degeneration FTD Sequencing Consortium: Discovery, replication and validation (UG3/UH3)
    (RFA-NS-17-017)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s